Fusing journalism and TB – telling the stories as they are

The First New Tuberculosis Drug in Decades: Promise and Challenges

leave a comment »

It is estimated that up to one-third of the world’s population—over two billion people—are infected with TB, and each one of them is a potential future case of TB disease. According to the WHO Global Tuberculosis Control Report 2010, TB remains the leading killer of people with HIV, accounting for at least a quarter of all HIV deaths in 2009. Despite being curable, TB claimed 4,700 lives each day—or the lives of 1.7 million people that same year.

After nearly 50 years, there is finally something to get excited about in tuberculosis (TB) drug development. Tibotec’s TMC207—the first compound from a novel class of TB drugs, the diarylquinolines—will likely be submitted to the U.S. Food and Drug Administration and the European Medicines Agency for accelerated or conditional approval sometime in 2012.

Read more

Written by JournalistsAgainstTB

March 6, 2011 at 7:58 am

Posted in TB and Media

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: